Plethora Solutions Holdings Overview
- Founded
- 2003
- Status
- Acquired/Merged
- Employees
- 51
- Latest Deal Type
- M&A
- Financing Rounds
- 10
- Investments
- 1
Plethora Solutions Holdings General Information
Description
Developer of treatments for urological disorders.The company focuses on acquiring, developing and marketing products for the treatment and management of these disorders.
Contact Information
Website
www.plethorasolutions.co.uk
Formerly Known As
Copperspice
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Other Commercial Services
Other Industries
Pharmaceuticals
Drug Discovery
Therapeutic Devices
Discovery Tools (Healthcare)
Parent Company
Primary Office
- Hampden House
- Monument Business Park, Warpsgrove Lane
- Chalgrove OX44 7RW
- England, United Kingdom
+44 020 0000 0000
Plethora Solutions Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Plethora Solutions Holdings‘s full profile, request access.
Request a free trialPlethora Solutions Holdings Patents
Plethora Solutions Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2004518646-A | Topical compositions and methods for treating stress urinary incontinence | Pending | 15-Dec-2000 | 0000000000 | |
| CA-2431519-A1 | Topical composition and method for treating urinary stress incontinence | Granted | 15-Dec-2000 | 0000000000 | |
| US-20040044082-A1 | Adrenergic receptor antagonist | Abandoned | 15-Dec-2000 | 0000000000 | 0 |
| ES-2260160-T7 | Topical composition and procedure to treat urinary incontinence of effort. | Active | 15-Dec-2000 | 0000000000 | |
| CA-2431519-C | Topical composition and method for treating urinary stress incontinence | Expired - Fee Related | 15-Dec-2000 | A61K9/0034 |
Plethora Solutions Holdings Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jamie Gibson | Chief Executive Officer & Executive Director | ||
| Michael Wyllie Ph.D | Co-Founder, Chief Scientific Officer & Board Member |
Plethora Solutions Holdings Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 00000000 | Plethora Solutions Holdings | Independent Non-Executive Director | 000 0000 |
| 0000000 000000 00 | Self | Independent Non-Executive Director | 000 0000 |
| 00000 000000 | Plethora Solutions Holdings | Chief Executive Officer & Executive Director | 000 0000 |
| 000 000000 | Endurance RP | Chairman & Non-Executive Director | 000 0000 |
| 0000000 000000 00.0 | Plethora Solutions Holdings | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Plethora Solutions Holdings Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPlethora Solutions Holdings Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Plethora Solutions Holdings‘s full profile, request access.
Request a free trialPlethora Solutions Holdings Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 0000000 | 10-Feb-2006 | 0000000000 | 00.00 | Therapeutic Devices |
Plethora Solutions Holdings Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 0000000 00000 | 10-Feb-2006 | 000000000000000000 | 00.00 | Completed |
|